The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a Scientific Conclave and Interactive Session on Indian Pharmacopoeia (IP) 2026 “Strengthening Pharmaceutical Manufacturing through Pharmacopoeial Standards and Quality Compliance” at Haridwar yesterday, in collaboration with the Association of Devbhumi Pharma Industries (ADPI) and affiliated pharmaceutical manufacturing associations of Uttarakhand. The conclave was organized with the objective of enhancing awareness on the provisions of IP 2026 and promoting quality compliance across the pharmaceutical manufacturing sector.
Uttarakhand is one of India’s leading pharmaceutical manufacturing hubs and has been among the states effectively utilizing the IP and Indian Pharmacopoeia Reference Substances for ensuring the quality, safety, and efficacy of medicines. Recognizing the state’s significant contribution to pharmaceutical manufacturing, the conclave was organized to further strengthen industry awareness, support compliance with pharmacopoeial requirements, and promote the consistent adoption of IP standards across the pharmaceutical sector, thereby providing handholding support to pharmaceutical manufacturers and other stakeholders in the state.
The programme brought together representatives from pharmaceutical manufacturing units, quality control and quality assurance professionals, regulatory authorities, analytical scientists, and drug testing laboratory personnel to deliberate on recent developments in pharmacopoeial standards and their implementation in the pharmaceutical industry.
The inaugural session commenced with a welcome address by Shri Sandeep Jain, Chairman, ADPI. Addressing the gathering, he emphasized the importance of collaboration between industry and standard-setting bodies in strengthening pharmaceutical quality systems.
The session was also addressed by Shri Sidharth Sahai Malhotra, Assistant Drugs Controller (India), CDSCO, Dehradun, and Shri Tajber Singh, Drug Controller and State Licensing Authority, Uttarakhand, who highlighted the critical role of pharmacopoeial standards in ensuring regulatory compliance and safeguarding public health.
